The Latest Breaking News from Omicron

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

Around one in five vaccinated Britons with Omicron or Delta strain experienced diarrhoea as a symptom

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

UK hit by fifth wave of infections earlier this summer driven by new Omicron variants

Fainting and fatigue may signal onset of variant, experts say

CDC advisers endorse booster shots that target omicron for Americans 12 and up

Ballarat CBD businesses will be watching GovHub keenly in the weeks to come to see what impact the change of COVID work from home rules will have on the underutilised building. On Thursday Victorians were encouraged to return to the office, with the government lifting its work from home recommendation.…

The United States should replace most of its COVID-19 booster shots with updated versions that target the dominant omicron strains, an influential group of vaccine experts that advises the Centers for Disease Control and Prevention said Thursday.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia Therapeutics’ (NASDAQ:NTLA) lead asset NTLA-2002, for the treatment of hereditary angioedema (HAE). Intellia shares traded in a range of $56.52 to $60.06 on day volume of 901.43 thousand shares, closed regular trading session at $59.97. The company…

CDC Director Rochelle Walensky has signed off on updated versions of the Moderna and Pfizer-BioNTech vaccines that target the original virus and the omicron subvariants.